InvestorsHub Logo
Followers 5
Posts 1278
Boards Moderated 0
Alias Born 04/15/2019

Re: None

Monday, 02/21/2022 1:30:03 PM

Monday, February 21, 2022 1:30:03 PM

Post# of 3353
Brainstorm Cell Therapeutics Announces Grant of a New Brazilian Patent Covering Methods of Manufacturing NurOwn

https://ir.brainstorm-cell.com/2022-02-15-Brainstorm-Cell-Therapeutics-Announces-Grant-of-a-New-Brazilian-Patent-Covering-Methods-of-Manufacturing-NurOwn-R

"We are committed to the development of NurOwn as a potential treatment for ALS and other neurodegenerative diseases. This patent, which covers the industrial manufacturing process for NurOwn® developed by Brainstorm's scientists, enhances our ability to do so worldwide," said Chaim Lebovits, Chief Executive Officer, Brainstorm Cell Therapeutics. "A strong IP portfolio is important in establishing commercial preparedness as we work urgently toward a regulatory pathway. Adding a Brazilian patent to our existing portfolio of US, Canadian, EU, Israel and Japanese patents should position us well to enter into new commercial partnerships for NurOwn® in South America and worldwide."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCLI News